NCT07004478 Turkish Adaptation Study of the Generic Functional Index
| NCT ID | NCT07004478 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Bilgi University |
| Condition | Musculoskeletal Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-07-01 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Generic Functional Index is a scale developed to assess the general functional status of individuals. This study aims to evaluate the validity and reliability of the Turkish version of the Generic Functional Index. The adaptation process was designed to follow a standardized translation protocol, including forward translation, expert committee review, back-translation, pilot testing, and psychometric analyses. Data will be collected from individuals with musculoskeletal problems. Psychometric testing will include test-retest reliability, internal consistency, and construct validity analyses. The main hypotheses of this study are as follows: 1. The Turkish version of the Generic Functional Index will demonstrate high test-retest reliability when administered to individuals with musculoskeletal disorders. 2. The scores of the Turkish version of the Generic Functional Index will show a significant positive correlation with the scores of the Functional Independence Measure in individuals with musculoskeletal disorders.
Eligibility Criteria
Inclusion Criteria: * Being 18 years of age or older, * Turkish literacy, * Cognitive competence, * Having a musculoskeletal disorder Exclusion Criteria: * Those with acute functional impairment * Those with cognitive impairment, or * Those with a mental or physical condition that would prevent them from understanding the scale.
Contact & Investigator
Elif Elcin Dereli, Prof.
STUDY DIRECTOR
Istanbul Bilgi University
Frequently Asked Questions
Who can join the NCT07004478 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Musculoskeletal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07004478 currently recruiting?
Yes, NCT07004478 is actively recruiting participants. Contact the research team at fztfurkancakir@gmail.com for enrollment information.
Where is the NCT07004478 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07004478 clinical trial?
NCT07004478 is sponsored by Istanbul Bilgi University. The principal investigator is Elif Elcin Dereli, Prof. at Istanbul Bilgi University. The trial plans to enroll 200 participants.